Related references
Note: Only part of the references are listed.Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study
Milind Javle et al.
Lancet Gastroenterology & Hepatology (2021)
Dichloromethane increases mutagenic DNA damage and transformation ability in cholangiocytes and enhances metastatic potential in cholangiocarcinoma cell lines
Angkhameen Buranarom et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2021)
Cholangiocarcinoma
Paul J. Brindley et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Systemic therapies for intrahepatic cholangiocarcinoma
Robin Kate Kelley et al.
JOURNAL OF HEPATOLOGY (2020)
Infigratinib in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: the PROOF 301 trial
Shalini Makawita et al.
FUTURE ONCOLOGY (2020)
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Jesus M. Banales et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Mutant Isocitrate Dehydrogenase Inhibitors as Targeted Cancer Therapeutics
Danielle Golub et al.
FRONTIERS IN ONCOLOGY (2019)
Establishment and Characterization of Two Novel Cholangiocarcinoma Cell Lines
Yanhua Zhang et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Preclinical In Vitro and In Vivo Evidence of an Antitumor Effect of CX-4945, a Casein Kinase II Inhibitor, in Cholangiocarcinom
Kais Zakharia et al.
TRANSLATIONAL ONCOLOGY (2019)
Cholangiocarcinoma - evolving concepts and therapeutic strategies
Sumera Rizvi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Targeting cholangiocarcinoma
Joachim C. Mertens et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Liver Fluke-Associated Biliary Tract Cancer
Piyapan Prueksapanich et al.
GUT AND LIVER (2018)
Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma
Milind Javle et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
An update on cancer risk and surveillance in primary sclerosing cholangitis
Jennifer L. Horsley-Silva et al.
LIVER INTERNATIONAL (2017)
Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma
Apinya Jusakul et al.
CANCER DISCOVERY (2017)
Investigation of Cross-Contamination and Misidentification of 278 Widely Used Tumor Cell Lines
Yaqing Huang et al.
PLOS ONE (2017)
Primary Sclerosing Cholangitis What the Gastroenterologist and Hepatologist Needs to Know
Andrea A. Gossard et al.
CLINICS IN LIVER DISEASE (2017)
Forty-Year Trends in Cholangiocarcinoma Incidence in the US: Intrahepatic Disease on the Rise
Supriya K. Saha et al.
ONCOLOGIST (2016)
Antitumor effect of the novel sphingosine kinase 2 inhibitor ABC294640 is enhanced by inhibition of autophagy and by sorafenib in human cholangiocarcinoma cells
Xiwei Ding et al.
ONCOTARGET (2016)
Primary Sclerosing Cholangitis as a Premalignant Biliary Tract Disease: Surveillance and Management
Sumera Rizvi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Incidence and mortality trends for biliary tract cancers in Austria
Matthias Pinter et al.
LIVER INTERNATIONAL (2014)
Integrated Genomic Characterization Reveals Novel, Therapeutically Relevant Drug Targets in FGFR and EGFR Pathways in Sporadic Intrahepatic Cholangiocarcinoma
Mitesh J. Borad et al.
PLOS GENETICS (2014)
Biliary Tract Cancers in Olmsted County, Minnesota, 1976-2008
Ju Dong Yang et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany
Thomas von Hahn et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2011)
Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100)
Banchob Sripa et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Establishment and characterisation of six human biliary tract cancer cell lines
JL Ku et al.
BRITISH JOURNAL OF CANCER (2002)
Short tandem repeat profiling provides an international reference standard for human cell lines
JR Masters et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
